Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000543,serum glucose level,,,,94.38,mg/dl,2.9639,7.26,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,fasting (for 16 hours),70236,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000543,serum glucose level,,,,78.045,mg/dl,1.4819,3.63,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,fasting (for 16 hours),70237,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000543,serum glucose level,,,,88.935,mg/dl,1.4819,3.63,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70238,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000543,serum glucose level,,,,74.415,mg/dl,3.7049,9.075,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70239,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000543,serum glucose level,,,,375.705,mg/dl,12.5965,30.855,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70240,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000543,serum glucose level,,,,252.285,mg/dl,28.1569,68.97,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70241,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000358,serum insulin level,,,,0.01334,mg/dl,5.0E-4,0.0012,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70274,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000358,serum insulin level,,,,0.00638,mg/dl,9.0E-4,0.0023,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70275,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000358,serum insulin level,,,,0.01218,mg/dl,0.0017,0.0041,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70276,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000358,serum insulin level,,,,0.00986,mg/dl,5.0E-4,0.0012,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70277,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000358,serum insulin level,,,,0.116,mg/dl,0.0047,0.0116,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70278,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000358,serum insulin level,,,,0.0783,mg/dl,0.0166,0.0406,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70279,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",epididymal fat pad mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000658,epididymal fat pad weight to body weight ratio,fat pad weight/100g body weight,,,2.17,%,0.0816,0.2,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70232,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",epididymal fat pad mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000658,epididymal fat pad weight to body weight ratio,fat pad weight/100g body weight,,,0.78,%,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70233,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000360,serum triglyceride level,,,,178.76192,mg/dl,18.0642,44.248,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70213,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000360,serum triglyceride level,,,,47.78784,mg/dl,3.6128,8.8496,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70214,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000360,serum triglyceride level,,,,276.99248,mg/dl,43.354,106.1952,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70215,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000360,serum triglyceride level,,,,61.9472,mg/dl,7.2257,17.6992,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70216,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000360,serum triglyceride level,,,,2412.40096,mg/dl,173.416,424.7808,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70219,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood triglyceride amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000360,serum triglyceride level,,,,46.90288,mg/dl,3.6128,8.8496,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70220,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000547,serum free fatty acids level,,,,1.05,mmol/l,0.0408,0.1,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70228,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000547,serum free fatty acids level,,,,1.12,mmol/l,0.0816,0.2,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70229,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000547,serum free fatty acids level,,,,1.56,mmol/l,0.0408,0.1,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70230,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000547,serum free fatty acids level,,,,1.26,mmol/l,0.0816,0.2,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70231,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000547,serum free fatty acids level,,,,4.13,mmol/l,0.1225,0.3,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70234,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000547,serum free fatty acids level,,,,1.4,mmol/l,0.0816,0.2,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70235,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0000715,SHR/OlaIpcv,male,0 days,6,,CMO:0000547,serum free fatty acids level,,,,1.28,mmol/l,0.0163,0.04,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70288,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood free fatty acid amount,,RS:0001422,SHR.PD-(D8Mgh9-D8Rat149)/Cub,male,0 days,6,,CMO:0000547,serum free fatty acids level,,,,1.58,mmol/l,0.0367,0.09,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70289,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,15152.7271212,(mg/dl) x min,298.3924,730.9091,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,fasting (for 16 hours),70268,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,14454.54531,(mg/dl) x min,247.1758,605.4545,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,fasting (for 16 hours),70269,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,15169.0907574,(mg/dl) x min,239.0108,585.4545,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70270,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,15850.9089324,(mg/dl) x min,1065.1569,2609.0909,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70271,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,57081.817611,(mg/dl) x min,512.9083,1256.3636,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70272,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,42156.3632148,(mg/dl) x min,1723.55,4221.8181,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70273,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000012,body weight,,,,376.9,g,3.021,7.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,70205,control condition,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000012,body weight,,,,274.1,g,8.3691,20.5,MMO:0000016,body weighing method,,0.0,,,,,control condition,70206,control condition,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000012,body weight,,,,398,g,0.8573,2.1,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days),70207,controlled sucrose content diet (for 7 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000012,body weight,,,,291.1,g,10.2879,25.2,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days),70208,controlled sucrose content diet (for 7 days),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000012,body weight,,,,352.9,g,1.5513,3.8,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70211,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000012,body weight,,,,257.6,g,10.2879,25.2,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70212,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0002041,serum uric acid level,,,,66.6,umol/l,0.5715,1.4,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70280,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0002041,serum uric acid level,,,,72.3,umol/l,1.5513,3.8,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70281,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0002041,serum uric acid level,,,,110.2,umol/l,2.4903,6.1,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70282,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0002041,serum uric acid level,,,,101.8,umol/l,4.7765,11.7,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70283,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0002041,serum uric acid level,,,,67.2,umol/l,2.5311,6.2,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70284,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0002041,serum uric acid level,,,,107.3,umol/l,3.1843,7.8,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70285,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",kidney mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000622,single kidney wet weight to body weight ratio,,,,3.8,g/kg,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70286,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",kidney mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000622,single kidney wet weight to body weight ratio,,,,3,g/kg,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70287,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",heart mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000074,heart weight to body weight ratio,,,,3.4,g/kg,0.4082,1.0,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70209,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",heart mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000074,heart weight to body weight ratio,,,,3.6,g/kg,0.0408,0.1,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70210,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",liver mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000633,liver weight to body weight ratio,,,,41.7,g/kg,0.8165,2.0,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70217,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",liver mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000633,liver weight to body weight ratio,,,,35.7,g/kg,1.633,4.0,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70218,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),